Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Codeine	O
/	O
Penicillins	O
/	O
Sudafed	O
/	O
Demerol	O
/	O
Darvocet-N	O
100	O
/	O
Sulfa	O
(Sulfonamide	O
Antibiotics)	O
/	O
Bactrim	O
/	O
Dilaudid	O
Attending:	O
___.	O
Chief	O
Complaint:	O
MRSA	O
bacteremia	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Temporary	O
HD	O
line	O
___	O
MRI	O
of	O
spine	O
and	O
R	O
hip	O
requiring	O
anesthesia	O
History	O
of	O
Present	O
Illness:	O
___	O
is	O
a	O
___	O
woman	O
with	O
a	O
history	O
of	O
HTN,	O
IDDM	O
(A1c	O
6.5%),	O
obesity,	O
HFpEF,	O
CAD,	O
OSA,	O
ESRD	O
on	O
HD	O
___	O
(initiated	O
in	O
___,	O
tertiary	O
hyperparathyroidism,	O
presenting	O
as	O
a	O
transfer	O
from	O
___	O
with	O
MRSA	O
bacteremia.	O
Per	O
outside	O
records,	O
the	O
patient	O
was	O
admitted	O
to	O
___	O
on	O
___	O
after	O
being	O
noted	O
to	O
have	O
progressive	O
confusion	B-Delirium
after	O
HD	O
that	O
day.	O
On	O
initial	O
evaluation	O
she	O
was	O
noted	O
to	O
be	O
hypoxic	O
to	O
87%	O
on	O
RA	O
and	O
encephalopathic,	B-Delirium
with	O
labs	O
notable	O
for	O
troponin	O
elevation	O
with	O
peak	O
of	O
0.61	O
and	O
leukocytosis	O
to	O
15.7.	O
CT	O
head	O
and	O
CXR	O
were	O
reportedly	O
unremarkable	O
at	O
that	O
time.	O
Blood	O
cultures	O
drawn	O
at	O
HD	O
from	O
the	O
___	O
and	O
sent	O
to	O
___	O
grew	O
GPC	O
in	O
clusters,	O
and	O
subsequently	O
each	O
blood	O
culture	O
drawn	O
at	O
___	O
until	O
___	O
grew	O
MRSA	O
(sensitivities	O
otherwise	O
unknown).	O
Tunneled	O
HD	O
line	O
was	O
removed	O
___	O
with	O
culture	O
tip	O
also	O
growing	O
Staph.	O
The	O
patient	O
was	O
treated	O
with	O
vancomycin	O
and	O
aztreonam	O
before	O
ID	O
consult	O
recommended	O
de-escalation	O
to	O
vancomycin	O
alone.	O
There	O
was	O
concern	O
for	O
additional	O
infectious	O
nidus	O
given	O
persistence	O
of	O
positive	O
cultures	O
after	O
removal	O
of	O
HD	O
line;	O
patient	O
reportedly	O
had	O
right	O
hip	O
pain	O
so	O
there	O
was	O
a	O
plan	O
to	O
obtain	O
CT	O
hip	O
to	O
evaluate	O
for	O
effusion,	O
but	O
this	O
did	O
not	O
occur	O
prior	O
to	O
transfer.	O
Hospital	O
course	O
also	O
notable	O
for	O
respiratory	O
failure	O
requiring	O
brief	O
MICU	O
stay	O
that	O
was	O
attributed	O
to	O
volume	O
overload	O
and	O
OSA.	O
The	O
patient	O
underwent	O
HD	O
through	O
LUE	O
fistula	O
on	O
___,	O
but	O
the	O
fistula	O
reportedly	O
clotted	O
45	O
minutes	O
into	O
the	O
session	O
and	O
HD	O
was	O
aborted.	O
Nephrology	O
team	O
at	O
___	O
recommended	O
transfer	O
to	O
___	O
as	O
surgeon	O
who	O
placed	O
fistula	O
is	O
here.	O
On	O
arrival	O
to	O
the	O
floor,	O
patient	O
is	O
somewhat	O
confused,	B-Delirium
though	O
she	O
denies	O
pain	O
and	O
dyspnea.	O
She	O
reports	O
she	O
was	O
transferred	O
here	O
for	O
further	O
evaluation	O
of	O
her	O
fistula.	O
REVIEW	O
OF	O
SYSTEMS:	O
==================	O
Per	O
HPI,	O
otherwise	O
10-point	O
review	O
of	O
systems	O
was	O
negative.	O
Past	O
Medical	O
History:	O
Glaucoma	B-Visual_impairment
HTN	O
Kidney	O
Stones	O
Obesity	O
Sleep	O
Apnea	O
CAD	O
ESRD	O
on	O
HD	O
(initiated	O
in	O
___	O
DM2	O
-	O
on	O
insulin	O
HFpEF	O
Social	O
History:	O
___	O
Family	O
History:	O
Mother	O
had	O
MI	O
in	O
___,	O
Father	O
lung	O
CA,	O
3	O
brothers	O
all	O
deceased	O
from	O
heart	O
problems	O
and	O
one	O
with	O
MI	O
who	O
passed	O
at	O
age	O
___.	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
========================	O
VITALS:	O
T	O
98.9	O
BP	O
120/71	O
HR	O
78	O
RR	O
24	O
O2	O
sat	O
95	O
3L	O
GENERAL:	O
Lying	O
in	O
bed,	O
awakens	O
to	O
voice,	O
HEENT:	O
PERRL.	O
Visible	O
cataracts.	B-Visual_impairment
Sclera	O
appear	O
mildly	O
icteric.	O
MMM.	O
NECK:	O
No	O
cervical	O
lymphadenopathy.	O
Unable	O
to	O
visualize	O
JVD.	O
CARDIAC:	O
Regular	O
rhythm,	O
normal	O
rate.	O
Audible	O
S1	O
and	O
S2.	O
No	O
murmurs/rubs/gallops.	O
LUNGS:	O
Clear	O
to	O
limited	O
auscultation	O
in	O
anterior	O
fields	O
with	O
diminished	O
breath	O
sounds	O
at	O
bases.	O
Mildly	O
labored.	O
ABDOMEN:	O
Normal	O
bowels	O
sounds,	O
mildly	O
distended,	O
non-tender	O
to	O
deep	O
palpation	O
in	O
all	O
four	O
quadrants.	O
No	O
organomegaly.	O
EXTREMITIES:	O
No	O
clubbing,	O
cyanosis,	O
or	O
edema.	O
Pulses	O
DP/Radial	O
2+	O
bilaterally.	O
Palpable	O
thrill	O
in	O
LUE	O
fistula.	O
Right	O
knee	O
notably	O
warmer	O
than	O
left,	O
without	O
effusion.	O
Passive	O
range	O
of	O
motion	O
>	O
90	O
degrees	O
in	O
right	O
knee	O
without	O
pain.	O
SKIN:	O
Chronic	O
venous	O
stasis	O
changes.	O
Warm.	O
Cap	O
refill	O
<2s.	O
No	O
rashes.	O
NEUROLOGIC:	O
Oriented	B-Unspecified_cognitive_impairment
to	O
person	O
and	O
place,	O
month	O
but	O
not	B-Unspecified_cognitive_impairment
date.	B-Unspecified_cognitive_impairment
CN2-12	O
intact.	O
Does	O
not	O
fully	O
cooperate	O
with	O
strength	O
exam,	O
but	O
dorsi-and	O
plantarflexion	O
is	O
intact	O
bilaterally.	O
1+	O
patellar	O
reflexes	O
in	O
bilateral	O
lower	O
extremities.	O
Normal	O
sensation	O
in	O
bilateral	O
lower	O
extremities.	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
========================	O
Vitals:Reviewed	O
in	O
OMR.	O
HEENT:	O
Visible	O
cataracts.	B-Visual_impairment
MMM	O
NECK:	O
Supple.	O
Unable	O
to	O
visualize	O
JVD.	O
CARDIAC:	O
Regular	O
rhythm,	O
normal	O
rate.	O
Audible	O
S1	O
and	O
S2.	O
No	O
murmurs/rubs/gallops.	O
LUNGS:	O
diminished	O
breath	O
sounds	O
at	O
bases	O
w/	O
crackles	O
ABDOMEN:	O
obese,	O
non	O
distended,	O
non-tender	O
to	O
deep	O
palpation.	O
No	O
organomegaly.	O
EXTREMITIES:	O
No	O
clubbing,	O
cyanosis,	O
or	O
edema.	O
Pulses	O
DP/Radial	O
2+	O
bilaterally.	O
Palpable	O
thrill	O
in	O
LUE	O
fistula.	O
SKIN:	O
Chronic	O
venous	O
stasis	O
changes.	O
Warm.	O
Cap	O
refill	O
<2s.	O
No	O
rashes.	O
BACK:	O
no	O
pain	O
to	O
palpation	O
of	O
spine	O
NEUROLOGIC:	O
A&Ox3,	B-Delirium
___	O
strength	O
in	O
lower	O
extremities	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
===============	O
___	O
03:09AM	O
BLOOD	O
WBC-10.9*	O
RBC-3.55*	O
Hgb-9.7*	O
Hct-31.3*	O
MCV-88	O
MCH-27.3	O
MCHC-31.0*	O
RDW-15.1	O
RDWSD-48.6*	O
Plt	O
___	O
___	O
03:09AM	O
BLOOD	O
___	O
PTT-24.3*	O
___	O
___	O
03:09AM	O
BLOOD	O
Glucose-132*	O
UreaN-70*	O
Creat-7.8*	O
Na-135	O
K-5.0	O
Cl-95*	O
HCO3-25	O
AnGap-15	O
___	O
03:09AM	O
BLOOD	O
ALT-19	O
AST-23	O
LD(LDH)-235	O
AlkPhos-96	O
TotBili-0.3	O
___	O
03:09AM	O
BLOOD	O
Calcium-9.0	O
Phos-6.5*	O
Mg-2.1	O
___	O
03:09AM	O
BLOOD	O
Vanco-34.0*	O
___	O
03:47AM	O
BLOOD	O
___	O
pO2-68*	O
pCO2-47*	O
pH-7.33*	O
calTCO2-26	O
Base	O
XS--1	O
Comment-GREEN	O
TOP	O
___	O
03:45PM	O
JOINT	O
FLUID	O
___	O
RBC-___*	O
Polys-92*	O
___	O
Macro-5	O
___	O
03:45PM	O
JOINT	O
FLUID	O
Crystal-NONE	O
DISCHARGE	O
LABS	O
===============	O
___	O
06:26AM	O
BLOOD	O
Glucose-95	O
UreaN-36*	O
Creat-6.4*	O
Na-137	O
K-4.1	O
Cl-96	O
HCO3-27	O
AnGap-14	O
___	O
06:26AM	O
BLOOD	O
Vanco-14.7	O
PERTINENT	O
LABS	O
=================	O
___	O
12:22AM	O
BLOOD	O
___	O
___	O
07:00AM	O
BLOOD	O
Ret	O
Aut-2.4*	O
Abs	O
Ret-0.06	O
___	O
07:00AM	O
BLOOD	O
Hapto-227*	O
___	O
05:25AM	O
BLOOD	O
calTIBC-143*	O
Ferritn-746*	O
TRF-110*	O
___	O
05:05AM	O
BLOOD	O
PTH-83*	O
___	O
05:05AM	O
BLOOD	O
25VitD-53	O
MICROBIOLOGY:	O
=============	O
___	O
3:09	O
am	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine	O
(Preliminary):	O
STAPH	O
AUREUS	O
COAG	O
+.	O
Consultations	O
with	O
ID	O
are	O
recommended	O
for	O
all	O
blood	O
cultures	O
positive	O
for	O
Staphylococcus	O
aureus,	O
yeast	O
or	O
other	O
fungi.	O
FINAL	O
SENSITIVITIES.	O
Oxacillin	O
RESISTANT	O
Staphylococci	O
MUST	O
be	O
reported	O
as	O
also	O
RESISTANT	O
to	O
other	O
penicillins,	O
cephalosporins,	O
carbacephems,	O
carbapenems,	O
and	O
beta-lactamase	O
inhibitor	O
combinations.	O
RIFAMPIN	O
should	O
not	O
be	O
used	O
alone	O
for	O
therapy.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
STAPH	O
AUREUS	O
COAG	O
+	O
|	O
CLINDAMYCIN-----------<=0.25	O
S	O
ERYTHROMYCIN----------	O
=>8	O
R	O
GENTAMICIN------------	O
<=0.5	O
S	O
LEVOFLOXACIN----------	O
4	O
R	O
OXACILLIN-------------	O
=>4	O
R	O
RIFAMPIN--------------	O
<=0.5	O
S	O
TRIMETHOPRIM/SULFA----	O
<=0.5	O
S	O
VANCOMYCIN------------	O
1	O
S	O
Aerobic	O
Bottle	O
Gram	O
Stain	O
(Final	O
___:	O
GRAM	O
POSITIVE	O
COCCI	O
IN	O
PAIRS	O
AND	O
CLUSTERS.	O
___	O
6:30	O
am	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine	O
(Preliminary):	O
STAPH	O
AUREUS	O
COAG	O
+.	O
Consultations	O
with	O
ID	O
are	O
recommended	O
for	O
all	O
blood	O
cultures	O
positive	O
for	O
Staphylococcus	O
aureus,	O
yeast	O
or	O
other	O
fungi.	O
Susceptibility	O
testing	O
performed	O
on	O
culture	O
#	O
___	O
ON	O
___.	O
Aerobic	O
Bottle	O
Gram	O
Stain	O
(Final	O
___:	O
GRAM	O
POSITIVE	O
COCCI	O
IN	O
PAIRS	O
AND	O
CLUSTERS.	O
___	O
9:58	O
pm	O
BLOOD	O
CULTURE	O
Source:	O
Venipuncture.	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
STAPH	O
AUREUS	O
COAG	O
+.	O
Consultations	O
with	O
ID	O
are	O
recommended	O
for	O
all	O
blood	O
cultures	O
positive	O
for	O
Staphylococcus	O
aureus,	O
yeast	O
or	O
other	O
fungi.	O
Susceptibility	O
testing	O
performed	O
on	O
culture	O
#	O
___	O
___.	O
Aerobic	O
Bottle	O
Gram	O
Stain	O
(Final	O
___:	O
GRAM	O
POSITIVE	O
COCCI	O
IN	O
PAIRS	O
AND	O
CLUSTERS.	O
___	O
5:25	O
am	O
BLOOD	O
CULTURE	O
Source:	O
Line-RIJ.	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
___	O
11:34	O
am	O
URINE	O
Source:	O
___.	O
**FINAL	O
REPORT	O
___	O
Legionella	O
Urinary	O
Antigen	O
(Final	O
___:	O
NEGATIVE	O
FOR	O
LEGIONELLA	O
SEROGROUP	O
1	O
ANTIGEN.	O
(Reference	O
Range-Negative).	O
Performed	O
by	O
Immunochromogenic	O
assay.	O
A	O
negative	O
result	O
does	O
not	O
rule	O
out	O
infection	O
due	O
to	O
other	O
L.	O
pneumophila	O
serogroups	O
or	O
other	O
Legionella	O
species.	O
Furthermore,	O
in	O
infected	O
patients	O
the	O
excretion	O
of	O
antigen	O
in	O
urine	O
may	O
vary.	O
Joint	O
Analysis	O
(R	O
Knee)	O
___	O
03:45PM	O
JOINT	O
FLUID	O
___	O
RBC-___*	O
Polys-92*	O
___	O
Macro-5	O
___	O
03:45PM	O
JOINT	O
FLUID	O
Crystal-NONE	O
IMAGING	O
AND	O
REPORTS:	O
====================	O
CHEST	O
(PORTABLE	O
AP)	O
___	O
-Ill-defined	O
opacities	O
overlying	O
the	O
right	O
hemithorax	O
may	O
reflect	O
a	O
small	O
layering	O
pleural	O
effusion.	O
-Retrocardiac	O
opacity	O
likely	O
secondary	O
to	O
atelectasis	O
however	O
a	O
superimposed	O
infectious	O
process	O
cannot	O
be	O
excluded.	O
-Mild	O
pulmonary	O
vascular	O
congestion.	O
-Mild	O
cardiomegaly.	O
HIP	O
(UNILAT	O
2	O
VIEW)	O
W/PELVIS	O
(1	O
VIEW)	O
RIGHT	O
___	O
Mild	O
degenerative	O
changes,	O
but	O
no	O
radiographic	O
Findings	O
of	O
osteomyelitis	O
or	O
septic	O
arthritis.	O
If	O
there	O
remains	O
high	O
clinical	O
concern	O
for	O
the	O
diagnosis,	O
may	O
further	O
evaluate	O
with	O
MRI	O
and/or	O
joint	O
aspiration.	O
KNEE	O
(2	O
VIEWS)	O
RIGHT	O
___	O
No	O
fracture.	O
Moderate	O
degenerative	O
changes	O
with	O
chondrocalcinosis.	O
LIVER	O
OR	O
GALLBLADDER	O
US	O
(SINGLE	O
ORGAN)	O
___	O
Unremarkable	O
ultrasound	O
of	O
the	O
abdomen.	O
TEMP	O
DIALYSIS	O
LINE	O
PLCT	O
___	O
Successful	O
placement	O
of	O
a	O
temporary	O
triple	O
lumen	O
dialysis	O
catheter	O
via	O
the	O
right	O
internal	O
jugular	O
venous	O
approach.	O
The	O
tip	O
of	O
the	O
catheter	O
terminates	O
in	O
the	O
distal	O
superior	O
vena	O
cava.	O
The	O
catheter	O
is	O
ready	O
for	O
use.	O
CT	O
CHEST	O
W/O	O
CONTRAST	O
___	O
Mild	O
moderate	O
pulmonary	O
edema	O
with	O
small	O
right-sided	O
pleural	O
effusion.	O
No	O
confluent	O
airspace	O
consolidation	O
to	O
suggest	O
pneumonia.	B-Lower_respiratory_tract_infection
RENAL	O
US	O
___	O
FINDINGS:	O
The	O
evaluation	O
is	O
limited	O
secondary	O
to	O
patient	O
body	O
habitus.	O
No	O
hydronephrosis.	O
No	O
large	O
stones.	O
No	O
worrisome	O
masses.	O
Echogenic	O
appearance	O
of	O
the	O
renal	O
cortex	O
is	O
more	O
notable	O
on	O
the	O
left	O
than	O
on	O
the	O
right.	O
This	O
appearance	O
is	O
concerning	O
for	O
chronic	O
medical	O
renal	O
disease.	O
A	O
right	O
renal	O
simple	O
cyst	O
measures	O
up	O
to	O
4.0	O
cm.	O
Right	O
kidney:	O
9.2	O
cm	O
Left	O
kidney:	O
8.7	O
cm	O
The	O
bladder	O
is	O
only	O
minimally	O
distended	O
and	O
can	O
not	O
be	O
fully	O
assessed	O
on	O
the	O
current	O
study.	O
IMPRESSION:	O
No	O
hydronephrosis.	O
Echogenic	O
kidneys,	O
with	O
atrophy	O
more	O
notable	O
on	O
the	O
leftthan	O
right,	O
likely	O
reflect	O
chronic	O
medical	O
renal	O
disease.	O
AVF	O
Duplex	O
___	O
IMPRESSION:	O
Grossly	O
patent	O
left	O
upper	O
extremity	O
radial	O
artery	O
to	O
cephalic	O
vein	O
fistula.	O
Velocities	O
in	O
the	O
arterial	O
site	O
of	O
the	O
fistula	O
are	O
slightly	O
elevated.	O
Volumetric	O
flow	O
through	O
the	O
fistula	O
is	O
suboptimal	O
at	O
470	O
mL/min.	O
AV	O
FISTULOGRAM	O
___	O
FINDINGS:	O
1.	O
Short	O
to	O
medium	O
length	O
segment	O
complete	O
thrombosis	O
of	O
the	O
left	O
cephalic	O
arch.	O
2.	O
Restoration	O
of	O
flow	O
but	O
persistent	O
areas	O
of	O
narrowing	O
in	O
the	O
left	O
cephalic	O
arch	O
after	O
6	O
and	O
7	O
mm	O
balloon	O
plasty.	O
3.	O
Almost	O
complete	O
resolution	O
of	O
the	O
areas	O
of	O
narrowing	O
in	O
the	O
left	O
cephalic	O
arch	O
after	O
8	O
mm	O
balloon	O
plasty.	O
4.	O
Deployment	O
of	O
a	O
9	O
mm	O
x	O
5	O
cm	O
Viabahn	O
stent	O
in	O
the	O
left	O
cephalic	O
arch..	O
5.	O
Final	O
digital	O
subtraction	O
venogram	O
demonstrated	O
brisk	O
antegrade	O
flow	O
into	O
the	O
SVC	O
and	O
right	O
atrium	O
and	O
no	O
visualization	O
of	O
the	O
collaterals	O
which	O
likely	O
jailed	O
off	O
by	O
the	O
stent.	O
IMPRESSION:	O
Satisfactory	O
appearance	O
following	O
fistulogram	O
and	O
deployment	O
of	O
a	O
9	O
mm	O
x	O
5	O
cm	O
Viabahn	O
stent	O
in	O
the	O
left	O
cephalic	O
arch	O
with	O
a	O
good	O
angiographic	O
and	O
clinical	O
result.	O
TTE	O
___	O
CONCLUSION:	O
The	O
left	O
atrial	O
volume	O
index	O
is	O
normal.	O
There	O
is	O
no	O
evidence	O
for	O
an	O
atrial	O
septal	O
defect	O
by	O
2D/color	O
Doppler.	O
The	O
estimated	O
right	O
atrial	O
pressure	O
is	O
___	O
mmHg.	O
There	O
is	O
normal	O
left	O
ventricular	O
wall	O
thickness	O
with	O
a	O
normal	O
cavity	O
size.	O
There	O
is	O
normal	O
regional	O
and	O
global	O
left	O
ventricular	O
systolic	O
function.	O
Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal.	O
The	O
visually	O
estimated	O
left	O
ventricular	O
ejection	O
fraction	O
is	O
60%.	O
There	O
is	O
no	O
resting	O
left	O
ventricular	O
outflow	O
tract	O
gradient.	O
No	O
ventricular	O
septal	O
defect	O
is	O
seen.	O
The	O
right	O
ventricle	O
was	O
not	O
well	O
seen	O
with	O
normal	O
free	O
wall	O
motion.	O
Tricuspid	O
annular	O
plane	O
systolic	O
excursion	O
(TAPSE)	O
is	O
normal.	O
The	O
aortic	O
sinus	O
diameter	O
is	O
normal	O
for	O
gender	O
with	O
normal	O
ascending	O
aorta	O
diameter	O
for	O
gender.	O
The	O
aortic	O
arch	O
diameter	O
is	O
normal	O
with	O
a	O
normal	O
descending	O
aorta	O
diameter.	O
The	O
abdominal	O
aorta	O
is	O
mildly	O
dilated.	O
There	O
is	O
no	O
evidence	O
for	O
an	O
aortic	O
arch	O
coarctation.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened.	O
No	O
masses	O
or	O
vegetations	O
are	O
seen	O
on	O
the	O
aortic	O
valve.	O
There	O
is	O
no	O
aortic	O
valve	O
stenosis.	O
There	O
is	O
no	O
aortic	O
regurgitation.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
with	O
no	O
mitral	O
valve	O
prolapse.	O
A	O
moderate	O
(~1	O
cm,mobile)	O
echodensity	O
is	O
seen	O
on	O
the	O
left	O
atrial	O
side	O
of	O
the	O
mitral	O
valve,	O
immediately	O
adjacent	O
to	O
the	O
dense	O
posterior	O
annular	O
calcification.	O
The	O
echodensity	O
likely	O
represents	O
mobile	O
calcification,	O
but	O
a	O
thrombus	O
or	O
vegetation	O
(or	O
mixed	O
etiology)	O
is	O
also	O
possible.	O
There	O
is	O
moderate	O
mitral	O
annular	O
calcification.	O
There	O
is	O
trivial	O
mitral	O
regurgitation.	O
Due	O
to	O
acoustic	O
shadowing,	O
the	O
severity	O
of	O
mitral	O
regurgitation	O
could	O
be	O
UNDERestimated.	O
The	O
pulmonic	O
valve	O
leaflets	O
are	O
not	O
well	O
seen.	O
The	O
tricuspid	O
valve	O
leaflets	O
appear	O
structurally	O
normal.	O
No	O
mass/	O
vegetation	O
are	O
seen	O
on	O
the	O
tricuspid	O
valve.	O
There	O
is	O
physiologic	O
tricuspid	O
regurgitation.	O
The	O
pulmonary	O
artery	O
systolic	O
pressure	O
could	O
not	O
be	O
estimated.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
IMPRESSION:	O
A	O
moderate	O
sized	O
(0.6	O
x	O
1.0	O
x	O
1.0	O
cm)	O
mobile	O
echodensity	O
is	O
seen	O
on	O
the	O
left	O
atrial	O
side	O
of	O
the	O
posterior	O
leaflet	O
of	O
the	O
mitral	O
valve,	O
with	O
differential	O
diagnosis	O
as	O
above.	O
No	O
clinicallysignificant	O
mitral	O
regurgitation.	O
Normal	O
biventricular	O
cavity	O
sizes	O
and	O
regional/global	O
biventricular	O
systolic	O
function.	O
CT	O
A/P	O
___	O
IMPRESSION:	O
1.	O
No	O
acute	O
intra-abdominal	O
or	O
pelvic	O
findings.	O
2.	O
Small	O
pleural	O
effusion.	O
Bilateral	O
Upper	O
Extremity	O
Vein	O
US	O
___	O
FINDINGS:	O
There	O
is	O
normal	O
flow	O
with	O
respiratory	O
variation	O
in	O
the	O
bilateral	O
subclavian	O
veins.	O
There	O
is	O
a	O
partially	O
occlusive	O
thrombus	O
in	O
the	O
distal	O
right	O
internal	O
jugular	O
vein	O
which	O
terminates	O
before	O
the	O
bifurcation	O
of	O
the	O
subclavian	O
vein.	O
The	O
left	O
internal	O
jugular	O
vein	O
is	O
patent.	O
The	O
bilateral	O
axillary,	O
and	O
brachial	O
veins	O
are	O
patent,	O
show	O
normal	O
color	O
flow,	O
spectral	O
doppler,	O
and	O
compressibility.	O
The	O
bilateral	O
basilic,	O
and	O
cephalic	O
veins	O
are	O
patent,	O
compressible	O
and	O
show	O
normal	O
color	O
flow.	O
A	O
left	O
upper	O
extremity	O
cephalic	O
vein	O
to	O
basilic	O
artery	O
fistula	O
is	O
present.	O
IMPRESSION:	O
Partially	O
occlusive	O
thrombus	O
within	O
the	O
right	O
internal	O
jugular	O
vein	O
which	O
terminates	O
before	O
the	O
bifurcation	O
with	O
the	O
subclavian	O
vein.	O
MRI	O
HIP	O
W/WO	O
CONTRAST	O
___	O
IMPRESSION:	O
1.	O
No	O
evidence	O
of	O
septic	O
arthritis	O
or	O
osteomyelitis.	O
2.	O
Nonspecific	O
asymmetric	O
muscular	O
edema	O
about	O
the	O
muscles	O
of	O
the	O
pelvis	O
and	O
hip,	O
could	O
represent	O
low-grade	O
strain	O
or	O
infectious/inflammatory	O
myositis,	O
without	O
abscess.	O
MRI	O
TOTAL	O
SPINE	O
W/WO	O
CONTRAST	O
___	O
FINDINGS:	O
CERVICAL:	O
Alignment	O
is	O
normal.	O
Vertebral	O
body	O
and	O
intervertebral	O
disc	O
signal	O
intensity	O
appear	O
normal.	O
The	O
spinal	O
cord	O
appears	O
normal	O
in	O
caliber	O
and	O
configuration.	O
There	O
are	O
multilevel	O
degenerative	O
changes,	O
with	O
mild	O
posterior	O
disc	O
bulges	O
and	O
uncovertebral	O
and	O
facet	O
osteophytes.	O
Mild	O
central	O
canal	O
narrowing	O
cervical	O
spine.	O
Multilevel	O
mild-to-moderate	O
foraminal	O
narrowing.	O
There	O
is	O
no	O
abnormal	O
enhancement	O
after	O
contrast	O
administration.	O
THORACIC:	O
Alignment	O
is	O
normal.	O
Vertebral	O
body	O
and	O
intervertebral	O
disc	O
signal	O
intensity	O
appear	O
normal.	O
The	O
spinal	O
cord	O
appears	O
normal	O
in	O
caliber	O
and	O
configuration.	O
There	O
are	O
mild	O
multilevel	O
degenerative	O
changes,	O
with	O
mild-to-moderate	O
central	O
canal	O
narrowing	O
upper	O
thoracic	O
spine	O
at	O
T3	O
level,	O
preserved	O
CSF.	O
There	O
is	O
no	O
abnormal	O
enhancement	O
after	O
contrast	O
administration.	O
LUMBAR:	O
Alignment	O
is	O
normal.There	O
is	O
STIR	O
hyperintensity	O
in	O
the	O
inferior	O
endplate	O
of	O
L4	O
and	O
of	O
much	O
of	O
the	O
L5	O
vertebral	O
body	O
with	O
extensive	O
edema,	O
enhancement	O
of	O
the	O
paraspinal	O
soft	O
tissues	O
laterally	O
and	O
posteriorly.	O
There	O
is	O
also	O
mild	O
post-contrast	O
enhancement	O
of	O
the	O
paraspinal	O
soft	O
tissues	O
at	O
this	O
level.	O
There	O
is	O
also	O
STIR	O
hyperintensity	O
of	O
the	O
right	O
lateral	O
aspect	O
of	O
the	O
disc.	O
Mild	O
inflammatory	O
changes	O
dorsal	O
epidural	O
space.	O
No	O
fluid	O
collection.	O
Facet	O
joint	O
effusion,	O
may	O
be	O
reactive	O
or	O
early	O
infection.	O
(35:26).	O
Vertebral	O
body	O
signal	O
intensity	O
elsewhere	O
appears	O
normal	O
aside	O
from	O
mild	O
___	O
type	O
2	O
changes.	O
The	O
spinal	O
cord	O
appears	O
normal	O
in	O
caliber	O
and	O
configuration,	O
with	O
the	O
conus	O
medullaris	O
terminating	O
at	O
L1-2.There	O
are	O
multilevel	O
degenerative	O
changes,	O
worst	O
at	O
L4-5	O
and	O
L5-S1,	O
where	O
posterior	O
disc	O
bulge	O
and	O
facet	O
osteophytes	O
contribute	O
to	O
mild	O
spinal	O
canal	O
narrowing	O
and	O
mild	O
bilateral	O
neural	O
foraminal	O
narrowing,	O
with	O
no	O
definite	O
contact	O
with	O
the	O
exiting	O
or	O
traversing	O
nerve	O
roots.	O
OTHER:	O
Limited	O
views	O
of	O
the	O
abdomen	O
demonstrate	O
a	O
partially	O
imaged	O
a	O
wedge-shaped	O
T2	O
hyperintense,	O
hypoenhancing	O
lesion	O
in	O
the	O
spleen	O
concerning	O
for	O
infarct	O
and	O
small	O
bilateral	O
pleural	O
effusions	O
IMPRESSION:	O
1.	O
Findings	O
highly	O
suggestive	O
of	O
early	O
L4-5	O
discitis.	O
Paraspinal	O
edema.	O
2.	O
Bilateral	O
L4-5	O
facet	O
joint	O
effusions,	O
reactive	O
versus	O
early	O
infection.	O
3.	O
Extensive	O
paraspinal	O
edema	O
laterally	O
and	O
posteriorly	O
lumbar	O
spine.	O
4.	O
Mild-to-moderate	O
multilevel	O
degenerative	O
changes.	O
5.	O
Splenic	O
infarcts.	O
6.	O
Pleural	O
effusions.	O
7.	O
Presumed	O
atelectasis,	O
consider	O
infection	O
or	O
aspiration	O
if	O
appropriate.	O
Brief	O
Hospital	O
Course:	O
___	O
woman	O
with	O
a	O
history	O
of	O
HTN,	O
IDDM	O
(A1c	O
6.5%),	O
obesity,	O
HFpEF,	O
CAD,	O
OSA,	O
ESRD	O
on	O
HD	O
___	O
(initiated	O
in	O
___,	O
tertiary	O
hyperparathyroidism,	O
who	O
presented	O
as	O
a	O
transfer	O
from	O
___	O
with	O
MRSA	O
bacteremia	O
with	O
unclear	O
source	O
and	O
hypoxic	O
respiratory	O
failure	O
likely	O
___	O
volume	O
overload.	O
During	O
her	O
hospitalization,	O
she	O
had	O
an	O
extensive	O
workup	O
that	O
was	O
revealing	O
for	O
likely	O
infected	O
blood	O
clot	O
in	O
both	O
AVF	O
and	O
RIJ,	O
presumed	O
endocarditis	O
as	O
well	O
as	O
L4-L5	O
discitis.	O
Per	O
ID	O
recommendations,	O
she	O
should	O
continue	O
IV	O
vancomycin	O
with	O
HD	O
through	O
___.	O
Her	O
hospital	O
course	O
was	O
further	O
complicated	O
by	O
line	O
associated	O
clot	O
requiring	O
intiation	O
of	O
anticoagulation.	O
TRANSITIONAL	O
ISSUES	O
======================	O
[]	O
Patient	O
treated	O
for	O
MRSA	O
persistent	O
bacteremia	O
c/b	O
presumed	O
endocarditis	O
and	O
L4-L5	O
discitis.	O
Per	O
ID	O
recommendation	O
she	O
should	O
be	O
to	O
continue	O
on	O
vancomycin	O
dosed	O
with	O
hemodialysis	O
___	O
through	O
___.	O
[]	O
Essential	O
Dates	O
for	O
OPAT	O
therapy:	O
-	O
first	O
date	O
of	O
negative	O
blood	O
cx	O
___	O
-	O
tunneled	O
RIJ	O
HD	O
line	O
removed	O
___	O
[]	O
*PLEASE	O
OBTAIN	O
WEEKLY	O
CRP	O
for	O
patients	O
with	O
bone/joint	O
infections	O
and	O
endocarditis	O
or	O
endovascular	O
infections	O
while	O
on	O
vancomycin.	O
[]	O
The	O
___	O
will	O
schedule	O
follow	O
up	O
and	O
contact	O
the	O
patient	O
or	O
discharge	O
facility.	O
All	O
questions	O
regarding	O
outpatient	O
parenteral	O
antibiotics	O
after	O
discharge	O
should	O
be	O
directed	O
to	O
the	O
___	O
R.N.s	O
at	O
___	O
or	O
to	O
the	O
on-call	O
ID	O
fellow	O
when	O
the	O
clinic	O
is	O
closed.	O
All	O
questions	O
regarding	O
outpatient	O
parenteral	O
antibiotics	O
after	O
discharge	O
should	O
be	O
directed	O
to	O
the	O
___	O
R.N.s	O
at	O
___	O
or	O
to	O
the	O
on-call	O
ID	O
fellow	O
when	O
the	O
clinic	O
is	O
closed.	O
[]	O
Per	O
discussion	O
with	O
renal	O
team	O
at	O
___,	O
patient's	O
home	O
diuretic	O
was	O
held	O
given	O
successful	O
UF	O
during	O
HD	O
sessions.	O
The	O
patient	O
was	O
discharged	O
from	O
the	O
hospital	O
without	O
a	O
diuretic	O
but	O
this	O
should	O
be	O
re-evaluated	O
if	O
it	O
is	O
difficult	O
to	O
remove	O
fluid.	O
[]	O
Patient's	O
home	O
amlodipine	O
and	O
imdur	O
were	O
held	O
in	O
the	O
setting	O
of	O
hypotension	O
during	O
HD.	O
These	O
medications	O
were	O
held	O
throughout	O
her	O
hospitalization	O
given	O
normotension	O
despite	O
holding	O
these	O
medications	O
raising	O
concern	O
for	O
possible	O
medication	O
non-compliance	O
prior	O
to	O
admission.	O
These	O
medications	O
were	O
also	O
held	O
at	O
discharge	O
but	O
patient	O
should	O
have	O
close	O
follow	O
up	O
of	O
her	O
blood	O
pressure	O
following	O
discharge.	O
[]	O
During	O
hospitalization	O
patient	O
noted	O
to	O
have	O
line	O
associated	O
DVT	O
and	O
started	O
on	O
apixaban	O
5mg	O
BID.	O
Plan	O
to	O
anticoagulate	O
for	O
3	O
months.	O
Patient	O
started	O
on	O
___	O
with	O
prospective	O
end	O
date	O
___.	O
[]	O
Patient	O
found	O
to	O
have	O
mass	O
on	O
mitral	O
valve	O
thought	O
likely	O
to	O
be	O
calcification	O
that	O
was	O
likely	O
infected	O
versus	O
endocarditis	O
versus	O
clot.	O
Patient	O
was	O
evaluated	O
by	O
cardiology	O
and	O
cardiac	O
surgery	O
who	O
recommended	O
repeat	O
TTE	O
following	O
antibiotics	O
course	O
(prospective	O
date:	O
after	O
___	O
and	O
continue	O
antibiotics	O
and	O
anticoagulation	O
for	O
the	O
time	O
courses	O
previously	O
described.	O
Notably,	O
the	O
indication	O
for	O
her	O
Apixaban	O
is	O
NOT	O
cardiac	O
thrombosis	O
(it	O
is	O
DVT).	O
[]	O
Patient	O
with	O
Type	O
II	O
NSTEMI	O
at	O
OSH	O
thought	O
to	O
be	O
demand	O
ischemia	O
in	O
the	O
setting	O
of	O
infection.	O
Recommend	O
outpatient	O
stress	O
for	O
further	O
evaluation.	O
ACUTE/ACTIVE	O
ISSUES:	O
====================	O
#MRSA	O
bacteremia:	O
Persistent	O
MRSA	O
bacteremia	O
that	O
was	O
likely	O
originally	O
from	O
tunneled	O
HD	O
line	O
removed	O
at	O
OSH	O
given	O
positive	O
tip	O
culture,	O
but	O
there	O
was	O
concern	O
for	O
seeding	O
of	O
a	O
separate	O
site	O
given	O
refractory	O
bacteremia	O
despite	O
line	O
removal.	O
Pleural	O
effusion	O
assessed	O
and	O
only	O
minimal	O
R	O
pleural	O
effusion;	O
not	O
drained.	O
TTE	O
concerning	O
for	O
endocarditis	O
w/	O
mitral	O
valve	O
abnormality-	O
a	O
moderate	O
sized	O
(0.6	O
x	O
1.0	O
x	O
1.0	O
cm)	O
mobile	O
echodensity	O
seen	O
on	O
the	O
left	O
atrial	O
side	O
of	O
the	O
posterior	O
leaflet	O
of	O
the	O
mitral	O
valve	O
which	O
per	O
cards	O
evaluation	O
is	O
quite	O
consistent	O
w/	O
endocarditis,	O
would	O
not	O
benefit	O
from	O
further	O
evaluation	O
with	O
TEE	O
since	O
they	O
visualized	O
it	O
quite	O
well	O
on	O
the	O
TTE.	O
CT	O
A&P	O
w/out	O
acute	O
pathology.	O
RUE	O
US	O
w/	O
partially	O
occlusive	O
thrombus	O
within	O
the	O
right	O
internal	O
jugular	O
vein	O
which	O
terminates	O
before	O
the	O
bifurcation	O
with	O
the	O
subclavian	O
vein	O
and	O
may	O
explain	O
her	O
prolonger	O
bacteremia	O
(infected	O
clot)	O
which	O
abated	O
after	O
line	O
removal.	O
MRI	O
full	O
spine	O
and	O
hip	O
revealed	O
L4-L5	O
discitis	O
with	O
paraspinal	O
edema	O
likely	O
causing	O
her	O
right-sided	O
pain.	O
The	O
persistence	O
of	O
the	O
bacteremia	O
was	O
thought	O
to	O
be	O
due	O
to	O
additional	O
infection	O
of	O
clot	O
in	O
either	O
the	O
AVF	O
or	O
R	O
IJ	O
both	O
of	O
which	O
were	O
removed	O
as	O
below,	O
possible	O
endocarditis	O
(reviewed	O
below),	O
or	O
L4-L5	O
discitis.	O
She	O
was	O
continued	O
on	O
vancomycin	O
and	O
started	O
on	O
ceftaroline	O
as	O
well,	O
but	O
ceftaroline	O
was	O
discontinued	O
per	O
ID	O
recommendations.	O
Vancomycin	O
should	O
be	O
continued	O
through	O
___	O
given	O
finding	O
of	O
L4-L5	O
discitis	O
for	O
full	O
___	O
week	O
course.	O
#Hypoxemic	O
respiratory	O
failure:	O
Patient	O
presented	O
with	O
tachypnea	O
and	O
O2	O
requirement	O
thought	O
likely	O
___	O
volume	O
overload.	O
Home	O
torsemide	O
was	O
held.	O
Received	O
Lasix	O
with	O
limited	O
effect.	O
Temp	O
HD	O
line	O
placed	O
___.	O
Underwent	O
HD	O
which	O
was	O
initially	O
limited	O
by	O
hypotension.	O
Possibly	O
pneumonia	B-Lower_respiratory_tract_infection
seen	O
on	O
OSH	O
CT	O
chest,	O
however	O
repeat	O
NCCT	O
chest	O
at	O
___	O
w/	O
pulmonary	O
edema	O
and	O
right	O
pleural	O
effusion,	O
but	O
without	O
pneumonia.	B-Lower_respiratory_tract_infection
his	O
was	O
evaluated	O
by	O
IP	O
and	O
determined	O
to	O
be	O
too	O
small	O
to	O
tap.	O
It	O
resolved	O
with	O
further	O
HD.	O
Home	O
anti-HTN	O
was	O
held	O
to	O
give	O
BP	O
room	O
for	O
volume	O
removal	O
w/	O
HD.	O
Patient	O
underwent	O
dialysis	O
___	O
with	O
resolution	O
of	O
respiratory	O
symptoms.	O
#ESRD	O
on	O
HD:	O
#Clotted	O
fistula:	O
On	O
___	O
schedule.	O
Fistula	O
reportedly	O
clotted	O
at	O
OSH	O
after	O
45	O
minutes	O
of	O
use	O
on	O
___.	O
Volume	O
overloaded	O
likely	O
from	O
missing	O
HD	O
due	O
to	O
clotted	O
fistula.	O
Temporary	O
HD	O
line	O
placed	O
___	O
and	O
subsequently	O
removed	O
on	O
___.	O
HD	O
was	O
initially	O
limited	O
by	O
hypotension,	O
so	O
home	O
antihypertensives	O
were	O
held.	O
___	O
was	O
consulted	O
for	O
fistulogram.	O
during	O
fistulogram	O
(___)	O
patient	O
was	O
found	O
to	O
have	O
clot	O
which	O
was	O
removed	O
and	O
HD	O
was	O
continued	O
thereafter	O
through	O
AVF.	O
Continued	O
nephrocaps,	O
sevelamer,	O
calcitriol	O
#Right	O
Lower	O
Quadrant	O
Pain	O
During	O
the	O
hospitalization,	O
patient	O
began	O
reporting	O
significant	O
RLQ	O
pain	O
of	O
unclear	O
etiology.	O
Abdominal	O
imagining	O
including	O
US	O
and	O
CT	O
showed	O
no	O
acute	O
abdominal	O
process.	O
Given	O
persistence	O
of	O
RLQ	O
patient	O
underwent	O
MRI	O
which	O
she	O
initially	O
did	O
not	O
tolerate,	O
but	O
later	O
successfully	O
completed	O
with	O
anesthesia	O
where	O
she	O
was	O
found	O
to	O
have	O
L4-L5	O
discitis	O
as	O
well	O
as	O
muscle	O
strain	O
of	O
the	O
R	O
abdominal	O
wall.	O
It	O
was	O
thought	O
that	O
her	O
pain	O
was	O
referred	O
from	O
these	O
two	O
sites.	O
There	O
was	O
no	O
evidence	O
of	O
associated	O
osteomyelitis	O
of	O
the	O
R	O
hip	O
contributing	O
to	O
her	O
pain.	O
Her	O
pain	O
was	O
managed	O
with	O
tylenol,	O
lidocaine	O
patch	O
and	O
low	O
dose	O
oxycodone.	O
#Mass	O
on	O
TTE	O
Patient	O
with	O
mass	O
on	O
mitral	O
valve	O
on	O
TTE.	O
Although	O
there	O
was	O
good	O
visualization	O
of	O
the	O
mass,	O
it	O
is	O
unclear	O
what	O
this	O
mass	O
is	O
(vegetation,	O
thrombus,	O
calcification).	O
Per	O
cardiology	O
likely	O
calcification	O
or	O
endocarditis.	O
No	O
additional	O
imaging	O
warranted	O
at	O
this	O
time.	O
C-surg	O
recommends	O
no	O
indication	O
for	O
surgery.	O
Patient	O
was	O
treated	O
both	O
with	O
antibiotics	O
in	O
the	O
setting	O
that	O
mass	O
was	O
endocarditis,	O
and	O
was	O
on	O
anticoagulation	O
with	O
apixaban	O
for	O
possible	O
clot.	O
#R	O
Internal	O
Jugular	O
DVT	O
Line	O
associated	O
DVT	O
from	O
recent	O
HD	O
temp	O
line.	O
Potentially	O
another	O
source	O
of	O
infection.	O
Patient	O
was	O
initially	O
placed	O
on	O
a	O
heparin	O
gtt	O
but	O
was	O
transitioned	O
to	O
apixaban	O
with	O
plan	O
to	O
treat	O
for	O
3	O
months	O
(start	O
date	O
___.	O
#Splenic	O
Infarction	O
Patient	O
noted	O
on	O
MRI	O
to	O
have	O
splenic	O
infarcts.	O
The	O
etiology	O
of	O
these	O
infarcts	O
was	O
thought	O
to	O
be	O
either	O
septic	O
emboli	O
from	O
presumed	O
endocarditis	O
or	O
from	O
clots	O
(known	O
clots	O
in	O
AVF	O
and	O
RIJ).	O
Thereby	O
patient	O
was	O
treated	O
with	O
both	O
antibiotics	O
and	O
anticoagulation	O
as	O
explained	O
elsewhere.	O
#R	O
knee	O
effusion	O
#Chondrocalcinosis	O
Presented	O
with	O
R	O
knee	O
pain	O
and	O
effusion	O
on	O
XR.	O
Tapped	O
by	O
ortho	O
___.	O
<50k	O
PMNs	O
and	O
no	O
growth	O
to	O
date	O
on	O
culture	O
with	O
positive	O
blood	O
cultures,	O
unlikely	O
infected	O
per	O
ortho.	O
Findings	O
c/w	O
chondrocalcinosis	O
on	O
XR.	O
#Acute	O
encephalopathy:	B-Delirium
Confusion	B-Delirium
likely	O
toxic-metabolic	O
in	O
nature	O
from	O
renal	O
failure	O
with	O
inadequate	O
HD	O
and	O
ongoing	O
infection.	O
CT	O
head	O
negative	O
for	O
acute	O
process	O
at	O
OSH.	O
Mental	O
status	O
improved	O
with	O
treatment	O
of	O
infection	O
as	O
described	O
above.	O
#CAD	O
s/p	O
stent	O
to	O
LAD:	O
#Type	O
II	O
MI:	O
At	O
OSH,	O
trop	O
peak	O
at	O
0.61->0.49	O
and	O
EKG	O
w/o	O
acute	O
changes,	O
likely	O
demand	O
NSTEMI	O
from	O
infection.	O
Nuclear	O
stress	O
in	O
___	O
normal	O
perfusion.	O
Continued	O
ASA	O
and	O
atorvastatin.	O
HTN	O
meds	O
as	O
below.	O
#HTN:	O
Held	O
amlodipine,	O
imdur	O
for	O
HD	O
as	O
described	O
above.	O
CHRONIC/STABLE	O
ISSUES:	O
======================	O
#Normocytic	O
anemia:	O
Stable	O
with	O
prior,	O
likely	O
from	O
renal	O
disease.	O
Patient	O
demonstrated	O
no	O
signs	O
of	O
active	O
bleeding.	O
She	O
did	O
receive	O
1u	O
pRBCs	O
on	O
___.	O
#DM2:	O
Continued	O
on	O
glargine	O
4U	O
and	O
ISS.	O
#Hyperlipidemia:	O
Continued	O
on	O
home	O
atorvastatin.	O
#Glaucoma:	O
Continued	O
home	O
eye	O
drops	O
.	O
#	O
CODE:	O
Full,	O
presumed	O
#	O
CONTACT:	O
___,	O
___	O
>30	O
min	O
spent	O
on	O
dc	O
related	O
activities	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Acetaminophen	O
1000	O
mg	O
PO	O
Q8H:PRN	O
Pain	O
-	O
Mild/Fever	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
4.	O
Brimonidine	O
Tartrate	O
0.15%	O
Ophth.	O
1	O
DROP	O
BOTH	O
EYES	O
BID	O
5.	O
Calcitriol	O
0.25	O
mcg	O
PO	O
DAILY	O
6.	O
Dorzolamide	O
2%	O
Ophth.	O
Soln.	O
1	O
DROP	O
BOTH	O
EYES	O
BID	O
7.	O
Vitamin	O
D	O
___	O
UNIT	O
PO	O
DAILY	O
8.	O
Glargine	O
4	O
Units	O
Bedtime	O
9.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
30	O
mg	O
PO	O
DAILY	O
10.	O
Metoprolol	O
Succinate	O
XL	O
300	O
mg	O
PO	O
DAILY	O
11.	O
Nitroglycerin	O
SL	O
0.3	O
mg	O
SL	O
Q5MIN:PRN	O
chest	O
pain	O
12.	O
Pilocarpine	O
4%	O
1	O
DROP	O
BOTH	O
EYES	O
BID	O
13.	O
sevelamer	O
CARBONATE	O
800	O
mg	O
PO	O
TID	O
W/MEALS	O
14.	O
Torsemide	O
40	O
mg	O
PO	O
DAILY	O
15.	O
Travoprost	O
0.004	O
%	O
Ophth	O
Soln	O
(*NF*)	O
1	O
drop	O
Other	O
BID	O
16.	O
Nephrocaps	O
1	O
CAP	O
PO	O
DAILY	O
17.	O
amLODIPine	O
5	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Apixaban	O
5	O
mg	O
PO	O
BID	O
2.	O
Lidocaine	O
5%	O
Patch	O
1	O
PTCH	O
TD	O
QPM	O
back	O
pain	O
3.	O
Senna	O
8.6	O
mg	O
PO	O
BID	O
Please	O
hold	O
for	O
loose	O
stools.	O
4.	O
___	O
MD	O
to	O
order	O
daily	O
dose	O
IV	O
HD	O
PROTOCOL	O
5.	O
Glargine	O
4	O
Units	O
Bedtime	O
6.	O
Metoprolol	O
Succinate	O
XL	O
100	O
mg	O
PO	O
DAILY	O
7.	O
Acetaminophen	O
1000	O
mg	O
PO	O
Q8H:PRN	O
Pain	O
-	O
Mild/Fever	O
8.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
9.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
10.	O
Brimonidine	O
Tartrate	O
0.15%	O
Ophth.	O
1	O
DROP	O
BOTH	O
EYES	O
BID	O
11.	O
Calcitriol	O
0.25	O
mcg	O
PO	O
DAILY	O
12.	O
Dorzolamide	O
2%	O
Ophth.	O
Soln.	O
1	O
DROP	O
BOTH	O
EYES	O
BID	O
13.	O
Nephrocaps	O
1	O
CAP	O
PO	O
DAILY	O
14.	O
Nitroglycerin	O
SL	O
0.3	O
mg	O
SL	O
Q5MIN:PRN	O
chest	O
pain	O
15.	O
Pilocarpine	O
4%	O
1	O
DROP	O
BOTH	O
EYES	O
BID	O
16.	O
sevelamer	O
CARBONATE	O
800	O
mg	O
PO	O
TID	O
W/MEALS	O
17.	O
Travoprost	O
0.004	O
%	O
Ophth	O
Soln	O
(*NF*)	O
1	O
drop	O
Other	O
BID	O
18.	O
Vitamin	O
D	O
___	O
UNIT	O
PO	O
DAILY	O
19.Outpatient	O
Lab	O
Work	O
ICD-10:	O
___.62	O
ALL	O
LAB	O
RESULTS	O
SHOULD	O
BE	O
SENT	O
TO:	O
ATTN:	O
___	O
CLINIC	O
-	O
FAX:	O
___	O
VANCOMYCIN:	O
WEEKLY:	O
CBC	O
with	O
differential,	O
BUN,	O
Cr,	O
Vancomycin	O
trough	O
ADDITIONAL	O
ORDERS:	O
*PLEASE	O
OBTAIN	O
WEEKLY	O
CRP	O
for	O
patients	O
with	O
bone/joint	O
infections	O
and	O
endocarditis	O
or	O
endovascular	O
infections	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
PRIMARY	O
DIAGNOSIS	O
======================	O
MRSA	O
bacteremia	O
Hypoxemic	O
respiratory	O
failure	O
Right	O
Internal	O
Jugular	O
Deep	O
Vein	O
Thrombosis	O
Secondary	O
Diagnosis	O
=======================	O
Splenic	O
Infarcts	O
Normocytic	O
anemia	O
Mitral	O
Valve	O
Vegetation	O
ESRD	O
on	O
HD	O
Chondrocalcinosis	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Confused	B-Delirium
-	O
sometimes.	O
Level	O
of	O
Consciousness:	O
Lethargic	O
but	O
arousable.	O
Activity	O
Status:	O
Out	B-Mobile_with_assistance
of	B-Mobile_with_assistance
Bed	B-Mobile_with_assistance
with	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
to	O
chair	O
or	O
wheelchair.	B-Mobile_with_aid
Discharge	O
Instructions:	O
Dear	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
part	O
in	O
your	O
care	O
here	O
at	O
___!	O
Why	O
was	O
I	O
admitted	O
to	O
the	O
hospital?	O
-	O
You	O
were	O
admitted	O
for	O
bacteria	O
in	O
your	O
blood.	O
What	O
was	O
done	O
for	O
me	O
while	O
I	O
was	O
in	O
the	O
hospital?	O
-	O
You	O
received	O
antibiotics	O
for	O
your	O
infection.	O
-	O
You	O
received	O
medications	O
(diuretics)	O
to	O
help	O
remove	O
fluid	O
from	O
your	O
lungs.	O
-	O
You	O
got	O
a	O
temporary	O
dialysis	O
line	O
which	O
was	O
removed	O
once	O
your	O
fistula	O
was	O
fixed.	O
-	O
You	O
got	O
dialysis.	O
-	O
You	O
had	O
an	O
MRI	O
with	O
anesthesia	O
that	O
showed	O
the	O
blood	O
infection	O
also	O
affected	O
a	O
disc	O
in	O
the	O
spine.	O
This	O
can	O
be	O
treated	O
with	O
the	O
antibiotics	O
you	O
are	O
receiving.	O
We	O
think	O
this	O
is	O
what	O
was	O
causing	O
the	O
pain	O
in	O
your	O
side.	O
-	O
We	O
found	O
a	O
blood	O
clot	O
in	O
your	O
neck,	O
so	O
started	O
you	O
on	O
a	O
medicine	O
called	O
apixaban	O
which	O
is	O
a	O
blood	O
thinner.	O
What	O
should	O
I	O
do	O
when	O
I	O
leave	O
the	O
hospital?	O
-	O
Weigh	O
yourself	O
every	O
morning,	O
call	O
MD	O
if	O
weight	O
goes	O
up	O
more	O
than	O
3	O
lbs.	O
-	O
Continue	O
taking	O
your	O
medications	O
as	O
directed.	O
-	O
Keep	O
all	O
of	O
your	O
follow-up	O
appointments.	O
Sincerely,	O
Your	O
___	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

